"Trans-Activators" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins.
| Descriptor ID |
D015534
|
| MeSH Number(s) |
D12.776.260.755 D12.776.930.900 D12.776.964.925.984
|
| Concept/Terms |
Trans-Activators- Trans-Activators
- Trans Activators
- Transactivators
- Trans-Activator
- Trans Activator
- Transactivator
- Trans-Acting Factor
- Factor, Trans-Acting
- Trans Acting Factor
- Trans-Acting Factors
- Factors, Trans-Acting
- Trans Acting Factors
Nuclear Trans-Acting Factor- Nuclear Trans-Acting Factor
- Factor, Nuclear Trans-Acting
- Nuclear Trans Acting Factor
- Trans-Acting Factor, Nuclear
|
Below are MeSH descriptors whose meaning is more general than "Trans-Activators".
Below are MeSH descriptors whose meaning is more specific than "Trans-Activators".
This graph shows the total number of publications written about "Trans-Activators" by people in this website by year, and whether "Trans-Activators" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 7 | 2 | 9 |
| 1997 | 2 | 0 | 2 |
| 1998 | 11 | 2 | 13 |
| 1999 | 17 | 1 | 18 |
| 2000 | 17 | 2 | 19 |
| 2001 | 15 | 5 | 20 |
| 2002 | 26 | 7 | 33 |
| 2003 | 13 | 6 | 19 |
| 2004 | 20 | 17 | 37 |
| 2005 | 17 | 9 | 26 |
| 2006 | 4 | 5 | 9 |
| 2007 | 8 | 6 | 14 |
| 2008 | 6 | 6 | 12 |
| 2009 | 9 | 4 | 13 |
| 2010 | 14 | 6 | 20 |
| 2011 | 1 | 6 | 7 |
| 2012 | 7 | 4 | 11 |
| 2013 | 12 | 4 | 16 |
| 2014 | 6 | 6 | 12 |
| 2015 | 4 | 3 | 7 |
| 2016 | 3 | 3 | 6 |
| 2017 | 3 | 4 | 7 |
| 2018 | 5 | 5 | 10 |
| 2019 | 4 | 1 | 5 |
| 2020 | 1 | 2 | 3 |
| 2021 | 0 | 3 | 3 |
| 2022 | 1 | 0 | 1 |
| 2024 | 3 | 2 | 5 |
| 2025 | 2 | 0 | 2 |
| 2026 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Trans-Activators" by people in Profiles.
-
Asymmetric chromatin accessibility underlies anterior-posterior axis specification in moth fly embryos. PLoS Biol. 2026 Aug; 24(8):e3003896.
-
The FleQ-FleN circuit balances flagellar number against fitness in Pseudomonas aeruginosa. mBio. 2026 Sep 09; 17(9):e0036026.
-
Children With Pancreatic Hypoplasia Experience Poor Weight Gain and Labile Diabetes but Low Incidence of DKA. J Clin Endocrinol Metab. 2026 Mar 17; 111(4):e1164-e1173.
-
A clinical and genotype-phenotype analysis of MACF1 variants. Am J Hum Genet. 2025 10 02; 112(10):2363-2380.
-
Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicin. Blood. 2025 Jul 24; 146(4):471-481.
-
HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages. Nat Commun. 2024 06 29; 15(1):5514.
-
Altered extracellular matrix-related pathways accelerate the transition from normal to prefibroid myometrium in Black women. Am J Obstet Gynecol. 2024 09; 231(3):324.e1-324.e12.
-
RFX6 regulates human intestinal patterning and function upstream of PDX1. Development. 2024 05 01; 151(9).
-
Investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment. Nat Commun. 2024 May 01; 15(1):3681.
-
PU.1 and BCL11B sequentially cooperate with RUNX1 to anchor mSWI/SNF to poise the T cell effector landscape. Nat Immunol. 2024 May; 25(5):860-872.